De Zeng

938 citations

44 papers · 617 · h-index 15

Impact in

Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Oncology
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers

Papers in

Molecular Biology 26
- Epigenetics and DNA Methylation 9
- Renal and related cancers 4
- RNA modifications and cancer 3
- Cancer-related gene regulation 3
Oncology 19
- Cancer Cells and Metastasis 8
- HER2/EGFR in Cancer Research 3

Co-authors: Haoyu Lin (22 shared papers)Yuanke Liang (17 shared papers)Chunfa Chen (10 shared papers)Yingsheng Xiao (10 shared papers)Xiaolong Wei (8 shared papers)Guo‐Jun Zhang (8 shared papers)Shuming Sun (4 shared papers)Xiaofeng Lu (5 shared papers)
Journals: Cancer Letters (3 papers)Oncotarget (3 papers)Frontiers in Oncology (3 papers)Scientific Reports (2 papers)Frontiers in Public Health (2 papers)
Partner nations: China Netherlands Macao

In The Last Decade

De Zeng

37 papers receiving 610 citations

Peers

Countries citing papers authored by De Zeng

Since Specialization

Citations

This map shows the geographic impact of De Zeng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by De Zeng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites De Zeng more than expected).

Fields of papers citing papers by De Zeng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by De Zeng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by De Zeng. The network helps show where De Zeng may publish in the future.

Co-authors

The 25 scholars most cited alongside De Zeng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with De Zeng Line = papers co-authored together De Zeng links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Prognostic values of distinct CBX family members in breast cancer Oncotarget ·Yuanke Liang, Haoyu Lin, Chunfa Chen, De Zeng	2017	62
2	MCAM/CD146 promotes tamoxifen resistance in breast cancer cells through induction of epithelial–mesenchymal transition, decreased ERα expression and AKT activation Cancer Letters ·Yuanke Liang, De Zeng, Yingsheng Xiao, Yang Wu, Yan-Xiu Ouyang, Min Chen, Yaochen Li, Haoyu Lin, Xiaolong Wei, Yong‐Qu Zhang, Frank A.E. Kruyt, Guo‐Jun Zhang	2016	57
3	Major vault protein is a direct target of Notch1 signaling and contributes to chemoresistance in triple-negative breast cancer cells Cancer Letters ·Yingsheng Xiao, De Zeng, Yuanke Liang, Yang Wu, Meifang Li, Yuzhu Qi, Xiaolong Wei, Wen-Jia Chen, Min Chen, Guo‐Jun Zhang	2018	51
4	CXCL9 Is a Potential Biomarker of Immune Infiltration Associated With Favorable Prognosis in ER-Negative Breast Cancer Frontiers in Oncology ·Yuanke Liang, Ze-kun- Deng, Mu-tong CHEN, Si-Qi Qiu, Yingsheng Xiao, Yuzhu Qi, Qin Xie, Zheng-hao Wang, Shicheng Jia, De Zeng, Haoyu Lin	2021	40
5	Notch3 inhibits epithelial–mesenchymal transition in breast cancer via a novel mechanism, upregulation of GATA-3 expression Oncogenesis ·Haoyu Lin, Yuanke Liang, Xiaowei Dou, Chunfa Chen, Xiaolong Wei, De Zeng, Jing‐Wen Bai, Yuxian Guo, Fang-Fang Lin, Wen-Jia Chen, Caiwen Du, Yaochen Li, Min Chen, Guo‐Jun Zhang	2018	35
6	GATA3 and TRPS1 are distinct biomarkers and prognostic factors in breast cancer: database mining for GATA family members in malignancies Oncotarget ·Haoyu Lin, De Zeng, Yuanke Liang, Xiaolong Wei, Chunfa Chen	2017	35
7	Notch3 inhibits cell proliferation and tumorigenesis and predicts better prognosis in breast cancer through transactivating PTEN Cell Death and Disease ·Yong‐Qu Zhang, Yuanke Liang, Yang Wu, Min Chen, Weiling Chen, Ronghui Li, Yun‐Zhu Zeng, Wen‐He Huang, Jundong Wu, De Zeng, Wen‐Liang Gao, Chunfa Chen, Haoyu Lin, Ruiqin Yang, Jiang-Wen Zhu, Wan‐Ling Liu, Jing‐Wen Bai, Min Wei, Xiaolong Wei, Guo‐Jun Zhang	2021	34
8	FoxM1 is a promising candidate target in the treatment of breast cancer Oncotarget ·Xiaofeng Lu, De Zeng, Weiquan Liang, Chunfa Chen, Shuming Sun, Haoyu Lin	2017	33
9	<p><em>Long noncoding RNA H19</em> is a critical oncogenic driver and contributes to epithelial-mesenchymal transition in papillary thyroid carcinoma</p> Cancer Management and Research ·Weiquan Liang, De Zeng, Chunfa Chen, Shuming Sun, Xiaofeng Lu, Chunyan Peng, Haoyu Lin	2019	26
10	Predictive Value of Preoperative Multidetector-Row Computed Tomography for Axillary Lymph Nodes Metastasis in Patients With Breast Cancer Frontiers in Oncology ·Chunfa Chen, Yuling Zhang, Ze-Long Cai, Shuming Sun, Xiaofeng Lu, Haoyu Lin, Weiquan Liang, Ming‐Heng Yuan, De Zeng	2019	23
11	CD146 interaction with integrin β1 activates LATS1-YAP signaling and induces radiation-resistance in breast cancer cells Cancer Letters ·Yuanke Liang, Xiaoling Zhou, Qin Xie, Hexing Sun, Kaiyuan Huang, Huan Chen, Wende Wang, Benqing Zhou, Xiaolong Wei, De Zeng, Haoyu Lin	2022	23
12	Upregulation of SOX11 enhances tamoxifen resistance and promotes epithelial‐to‐mesenchymal transition via slug in MCF‐7 breast cancer cells Journal of Cellular Physiology ·Yingsheng Xiao, Qin Xie, Qingsong Qin, Yuanke Liang, Haoyu Lin, De Zeng	2020	23
13	Knockdown of nucleophosmin 1 suppresses proliferation of triple-negative breast cancer cells through activating CDH1/Skp2/p27kip1 pathway Cancer Management and Research ·De Zeng, Yingsheng Xiao, Jianling Zhu, Chunyan Peng, Weiquan Liang, Haoyu Lin	2018	21
14	FABP7 is a potential biomarker to predict response to neoadjuvant chemotherapy for breast cancer Cancer Cell International ·Qin Xie, Yingsheng Xiao, Shicheng Jia, Jie-xuan ZHENG, Zhen-chao DU, Yi‐Chun Chen, Mu-tong CHEN, Yuanke Liang, Haoyu Lin, De Zeng	2020	16
15	Over-expression of both VEGF-C and Twist predicts poor prognosis in human breast cancer Clinical & Translational Oncology ·Yuan Zhang, W.-L. Chen, Zhang Fuming, Xiaolong Wei, De Zeng, Yunsong Liang, Jundong Wu, Li-Xin Zhang, Chunbao Guo, Huan Zeng, Shuang Hao, Ruikun Li, Wen‐He Huang, Guo‐Jun Zhang	2019	16
16	Cancer-Related Fatigue and Chemotherapy-Associated Adverse Effects: Correlation with TNF-α, IL-1 and 17-Hydroxycorticosteroids Future Oncology ·Shuyao Zhang, De Zeng, Yu‐Hui Peng, Yuxian Yang, Xiaowen Zhuang, Zongtai Li, Miaojun Wang, Lei Chen, Hao Zhang	2014	13
17	TOX3 is a favorable prognostic indicator and potential immunomodulatory factor in lung adenocarcinoma Oncology Letters ·De Zeng, Haoyu Lin, Jianxiong Cui, Weiquan Liang	2019	12
18	Notch1 promotes resistance to cisplatin by up-regulating Ecto-5′-nucleotidase (CD73) in triple-negative breast cancer cells Cell Death Discovery ·Yuzhu Qi, Meifang Li, Shaozhong Li, De Zeng, Yingsheng Xiao, Jiwei Li, Qianqian Ye, Edwin Bremer, Guo‐Jun Zhang	2023	11
19	Online short videos promoting public breast cancer literacy: a pretest-posttest control group trial on efficiency, attitude, and influencing factors Frontiers in Public Health ·Qian-Rui Xu, Peizhu Wu, Jia-Zi Du, Wen-Jun Zhuang, Xiaotong He, Yongyong Ma, De Zeng, Yuanke Liang, Xiaoyang Xu, Lei Xie, Haoyu Lin	2023	10
20	Prognostic values of the inhibitor of DNA‑binding family members in breast cancer Oncology Reports ·Xiaoling Zhou, De Zeng, Yan‐Hong Ye, Shuming Sun, Xiaofeng Lu, Weiquan Liang, Chunfa Chen, Haoyu Lin	2018	10

About De Zeng

De Zeng is a scholar working on Molecular Biology, Oncology, Cancer Research, Pulmonary and Respiratory Medicine and Molecular Medicine, having authored 44 papers that have together received 617 indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (9 papers), Cancer Cells and Metastasis (8 papers), Ferroptosis and cancer prognosis (5 papers), Renal and related cancers (4 papers), HER2/EGFR in Cancer Research (3 papers), RNA modifications and cancer (3 papers), Cancer-related gene regulation (3 papers) and Cancer-related molecular mechanisms research (3 papers). The work is most often cited by research in Cancer Research (194 citations), Oncology (194 citations), Molecular Biology (392 citations), Pulmonary and Respiratory Medicine (127 citations) and Immunology (58 citations). De Zeng has collaborated with scholars based in China, Netherlands and Macao. Frequent co-authors include Haoyu Lin, Yuanke Liang, Chunfa Chen, Yingsheng Xiao, Xiaolong Wei, Guo‐Jun Zhang, Shuming Sun, Xiaofeng Lu, Yang Wu and Qin Xie. Their work appears in journals such as Cancer Letters, Oncotarget, Frontiers in Oncology, Scientific Reports and Frontiers in Public Health.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

De Zeng

Impact in

Papers in i

In The Last Decade

De Zeng

Peers

Countries citing papers authored by De Zeng

Fields of papers citing papers by De Zeng

All Works

About De Zeng

Explore authors with similar magnitude of impact

Papers in